Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$594M |
| 2 |
Microsoft
MSFT
|
+$460M |
| 3 |
Broadcom
AVGO
|
+$406M |
| 4 |
Cisco
CSCO
|
+$241M |
| 5 |
Meta Platforms (Facebook)
META
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$450M |
| 2 |
VMW
VMware, Inc
VMW
|
+$293M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$189M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$165M |
| 5 |
Danaher
DHR
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.62% |
| 2 | Healthcare | 12.35% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
UroGen Pharma
URGN
$2.25B
| $43K | ﹤0.01% |
2,868
+738
| +35% | +$9.58K |
|
2827
ReNew
RNW
$2.24B
| $42.4K | ﹤0.01% |
5,533
-5,144
| -48% | -$31.7K |
|
2828
Bowman Consulting
BWMN
$743M
| $42.2K | ﹤0.01% |
1,189
+61
| +5% | +$1.82K |
|
|
ONL
2829
Orion Office REIT
ONL
$156M
| $42.1K | ﹤0.01% |
7,368
-22,703
| -75% | -$118K |
|
|
VNET
2830
VNET Group
VNET
$2.1B
| $41.6K | ﹤0.01% |
14,491
| – | – |
|
2831
Miller Industries
MLR
$609M
| $41.6K | ﹤0.01% |
983
| – | – |
|
2832
GCM Grosvenor
GCMG
$827M
| $41.1K | ﹤0.01% |
4,582
-14,993
| -77% | -$125K |
|
|
FFWM
2833
DELISTED
First Foundation Inc
FFWM
| $40.7K | ﹤0.01% |
4,204
-62,529
| -94% | -$399K |
|
2834
Outset Medical
OM
$93.4M
| $40.7K | ﹤0.01% |
501
-2,248
| -82% | -$183K |
|
2835
ASE Group
ASX
$83.4B
| $40.7K | ﹤0.01% |
4,323
| – | – |
|
2836
Maplebear
CART
$11.8B
| $40K | ﹤0.01% |
1,707
-793
| -32% | -$19.9K |
|
2837
Caribou Biosciences
CRBU
$164M
| $39.8K | ﹤0.01% |
6,941
+747
| +12% | +$3.69K |
|
2838
AngioDynamics
ANGO
$650M
| $39.7K | ﹤0.01% |
5,065
-26,835
| -84% | -$186K |
|
2839
SoundThinking
SSTI
$104M
| $39.4K | ﹤0.01% |
1,543
-3,183
| -67% | -$64.9K |
|
2840
Telkom Indonesia
TLK
$14.7B
| $39.2K | ﹤0.01% |
1,520
| – | – |
|
2841
Viemed Healthcare
VMD
$360M
| $39K | ﹤0.01% |
5,010
| – | – |
|
2842
Avita Medical
RCEL
$236M
| $38.5K | ﹤0.01% |
2,805
-85
| -3% | -$974 |
|
2843
Prime Medicine
PRME
$571M
| $38.4K | ﹤0.01% |
4,336
-188
| -4% | -$1.45K |
|
2844
CNB Financial Corp
CCNE
$1.01B
| $38.2K | ﹤0.01% |
1,689
| – | – |
|
2845
Ocular Therapeutix
OCUL
$2.02B
| $37.8K | ﹤0.01% |
8,473
-436
| -5% | -$1.29K |
|
|
JBIO
2846
Jade Biosciences
JBIO
$1.31B
| $37.7K | ﹤0.01% |
48
-172
| -78% | -$87.6K |
|
|
DSKE
2847
DELISTED
Daseke, Inc. Common Stock
DSKE
| $37.7K | ﹤0.01% |
4,653
| – | – |
|
2848
CVRx
CVRX
$61.8M
| $37.7K | ﹤0.01% |
1,198
-114
| -9% | -$2.14K |
|
2849
Vanda Pharmaceuticals
VNDA
$296M
| $37.5K | ﹤0.01% |
8,897
-35,001
| -80% | -$141K |
|
2850
Limbach Holdings
LMB
$559M
| $37.2K | ﹤0.01% |
819
+61
| +8% | +$2.19K |
|
Similar funds
Legal & General Group's Q4 2023 Portfolio in Review
As of Q4 2023, Legal & General Group held 3,426 positions worth $322B, up 12% from $287B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 1.8%. Legal & General Group opened 15 new positions and exited 47, leaving the 3,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q4 2023 buy was WK Kellogg Co: 403,883 shares worth $5.31M.
- Legal & General Group added most to Apple in Q4 2023, an estimated $594M increase.
- Legal & General Group's biggest Q4 2023 reduction was Splunk Inc, cutting an estimated $165M.
- Legal & General Group fully exited Activision Blizzard in Q4 2023, selling an estimated $450M.
- Legal & General Group's ten largest holdings make up 26% of its $322B portfolio in Q4 2023.
- Legal & General Group opened 15 new positions and closed 47 in Q4 2023.
- Legal & General Group's portfolio value rose 12% quarter-over-quarter to $322B.
Based on Legal & General Group's 13F filing for Q4 2023, filed 15 Feb 2024.